Location History:
- Kalamazoo, MI (US) (2006 - 2007)
- Niantic, CT (US) (2008)
Company Filing History:
3 out of 523 
2 out of 202 Years Active: 2006-2008
Title: Jon S Jacobs: Innovator in Alzheimer's Disease Treatment
Introduction
Jon S Jacobs is a notable inventor based in Kalamazoo, MI (US), recognized for his contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. With a total of four patents to his name, Jacobs has made significant strides in developing compounds that target the underlying mechanisms of this debilitating condition.
Latest Patents
Jacobs' latest patents include innovative macrocycles that are useful in the treatment of Alzheimer's disease. One of his notable inventions is a macrocycle formula designed to inhibit the beta-secretase enzyme, which plays a crucial role in the formation of amyloid-beta peptides associated with Alzheimer's. This invention aims to reduce the formation of these peptides, offering potential therapeutic benefits. Another significant patent involves hydroxypropyl amides, which also serve as inhibitors of the beta-secretase enzyme. These compounds are similarly aimed at treating Alzheimer's disease and reducing amyloid-beta peptide deposition in mammals.
Career Highlights
Throughout his career, Jon S Jacobs has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn Company and Elan Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Jacobs has collaborated with notable colleagues such as Shon R Pulley and James Beck, further enhancing his research and development efforts in the pharmaceutical field.
Conclusion
Jon S Jacobs stands out as an influential inventor dedicated to advancing treatments for Alzheimer's disease through his innovative patents. His work continues to impact the pharmaceutical landscape, offering hope for improved therapies for those affected by this condition.